MBT-1805

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameMBT-1805

Drug Alias NameMBT-1805

ClassificationOther

Mechanisms of ActionPeroxisome proliferator-activated receptor α agonistsPeroxisome proliferator-activated receptor γ agonistsPeroxisome proliferator-activated receptor delta agonists

TargetsPeroxisome proliferator-activated receptor γPeroxisome proliferator-activated receptor deltaPeroxisome proliferator-activated receptor α

Therapy Area/IndicationsLiver Cirrhosis, Biliary

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBeijing Huayuanlong Medicine Technology Development Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Huayuanlong Medicine Technology Development Co Ltd

Inactive CompaniesN/A

Active IndicationsLiver Cirrhosis, Biliary

Inactive IndicationsN/A

Other Information

ATC CodeN/A